Nathaniel H. Fleming

406 total citations
15 papers, 294 citations indexed

About

Nathaniel H. Fleming is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nathaniel H. Fleming has authored 15 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Nathaniel H. Fleming's work include Cutaneous Melanoma Detection and Management (7 papers), Nonmelanoma Skin Cancer Studies (4 papers) and Immunotherapy and Immune Responses (3 papers). Nathaniel H. Fleming is often cited by papers focused on Cutaneous Melanoma Detection and Management (7 papers), Nonmelanoma Skin Cancer Studies (4 papers) and Immunotherapy and Immune Responses (3 papers). Nathaniel H. Fleming collaborates with scholars based in United States and Grenada. Nathaniel H. Fleming's co-authors include Iman Osman, Richard L. Shapiro, Inês Pires da Silva, Judy Zhong, Eleazar Vega‐Saenz de Miera, Eva Hernando, Jinhua Wang, Sung Won Han, Russell S. Berman and Douglas Hanniford and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Nathaniel H. Fleming

14 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathaniel H. Fleming United States 10 173 169 89 42 42 15 294
Lauren Meldi Sholl United States 11 178 1.0× 145 0.9× 53 0.6× 66 1.6× 30 0.7× 14 284
Roxana Obregon United States 8 264 1.5× 172 1.0× 56 0.6× 83 2.0× 49 1.2× 9 331
Morgan MacBeth United States 7 128 0.7× 187 1.1× 44 0.5× 19 0.5× 41 1.0× 15 273
Suresh Thummala United States 11 262 1.5× 178 1.1× 47 0.5× 112 2.7× 33 0.8× 12 364
Guilherme Francisco Brazil 10 108 0.6× 210 1.2× 94 1.1× 34 0.8× 36 0.9× 13 294
Gabriela Cinat Argentina 9 175 1.0× 170 1.0× 21 0.2× 28 0.7× 115 2.7× 20 318
Yatish Patil United Kingdom 6 245 1.4× 117 0.7× 98 1.1× 18 0.4× 84 2.0× 7 343
Ashwin Kotnis India 11 73 0.4× 174 1.0× 46 0.5× 44 1.0× 88 2.1× 27 312
Angelique M. Leonhart Netherlands 8 165 1.0× 184 1.1× 91 1.0× 29 0.7× 33 0.8× 9 349
Frank Friedrich Gellrich Germany 6 151 0.9× 97 0.6× 16 0.2× 42 1.0× 73 1.7× 19 240

Countries citing papers authored by Nathaniel H. Fleming

Since Specialization
Citations

This map shows the geographic impact of Nathaniel H. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel H. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel H. Fleming more than expected).

Fields of papers citing papers by Nathaniel H. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel H. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel H. Fleming. The network helps show where Nathaniel H. Fleming may publish in the future.

Co-authorship network of co-authors of Nathaniel H. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel H. Fleming. A scholar is included among the top collaborators of Nathaniel H. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel H. Fleming. Nathaniel H. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Fleming, Nathaniel H., Amber L. Bahorik, Feng Xia, & Kristine Yaffe. (2023). Risk of dementia in older veterans with multiple sclerosis. Multiple Sclerosis and Related Disorders. 82. 105372–105372. 3 indexed citations
2.
Chang, Gregory, Jennifer Wiggins, Nathaniel H. Fleming, et al.. (2020). TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors. Journal of Investigative Dermatology. 140(8). 1609–1618.e7. 14 indexed citations
3.
Fleming, Nathaniel H., Madeline Grade, & Eran Bendavid. (2018). Impact of primary care provider density on detection and diagnosis of cutaneous melanoma. PLoS ONE. 13(7). e0200097–e0200097. 14 indexed citations
4.
Kim, Caroline C., Elizabeth Berry, Michael A. Marchetti, et al.. (2018). Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatology. 154(12). 1401–1401. 22 indexed citations
5.
Fleming, Nathaniel H., Barbara M. Egbert, Jinah Kim, & Susan M. Swetter. (2016). Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi. JAMA Dermatology. 152(12). 1327–1327. 24 indexed citations
6.
Vogelsang, Matjaž, Inês Pires da Silva, Nathaniel H. Fleming, et al.. (2015). Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of Medical Genetics. 52(4). 231–239. 17 indexed citations
7.
Fleming, Nathaniel H., Inês Pires da Silva, Richard L. Shapiro, et al.. (2014). Analysis of Recurrence Patterns in Acral Versus Nonacral Melanoma: Should Histologic Subtype Influence Treatment Guidelines?. Journal of the National Comprehensive Cancer Network. 12(12). 1706–1712. 38 indexed citations
8.
Fleming, Nathaniel H., Judy Zhong, Inês Pires da Silva, et al.. (2014). Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 121(1). 51–59. 88 indexed citations
9.
Kern, Elizabeth, Nathaniel H. Fleming, Michelle Krogsgaard, et al.. (2014). Il10 Locus As a Biomarker of Melanoma Survival. Annals of Oncology. 25. iv80–iv80.
10.
Wengrod, Jordan, Eleazar Vega‐Saenz de Miera, Ding Wang, et al.. (2013). PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition. Molecular Cancer Research. 12(3). 433–439. 30 indexed citations
11.
Fleming, Nathaniel H., Jiaying Tian, Eleazar Vega‐Saenz de Miera, et al.. (2013). Impact of Age on the Management of Primary Melanoma Patients. Oncology. 85(3). 173–181. 14 indexed citations
12.
Qian, Meng, W. Michelle, Nathaniel H. Fleming, et al.. (2013). Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Melanoma Research. 23(6). 461–467. 23 indexed citations
13.
Shang, Shulian, Nathaniel H. Fleming, Richard L. Shapiro, et al.. (2013). Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival.. Journal of Clinical Oncology. 31(15_suppl). 9021–9021. 1 indexed citations
14.
Friedman, Erica B., Shulian Shang, Nathaniel H. Fleming, et al.. (2012). Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients. Journal of Biomedical Science and Engineering. 5(11). 647–651. 5 indexed citations
15.
Graham, Mark L., et al.. (2010). Circulating tumor cells (CTCs) and association with survival in molecular subtypes (MST) of metastatic breast cancer (MBC).. Journal of Clinical Oncology. 28(15_suppl). 1094–1094. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026